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Use of Transcutaneous Bilirubinometers on Newborns
• Transcutaneous bilirubinometers (TCBs) purchased 
for Mother Baby Unit (MBU) but not currently being 
used because there is no place to document results 
in EPIC. 
• Staff requires reeducation on how to safely and 
accurately use TCBs. 
• TCBs are a noninvasive method for testing jaundice 
risk in newborns which would:
– Reduce cost per patient.
– Save time (approximately 15 minutes to obtain serum 
bilirubin vs. 2 minutes to obtain transcutaneous bilirubin).
– Prevent invasive procedure for the infant.
• “Neonatal jaundice is a common physiological adaptation during 
the first week of postnatal life. Although the majority of infants 
have a mild clinical course without neurological morbidity, 
permanent neurological sequelae may occur with severe 
hyperbilirubinemia.” (Kitsommart., et al, 2016)
• “The use of the transcutaneous device is a lower cost screening 
solution for assessing the risk of hyperbilirubinemia in neonates 
than blood sampling methods.” (McKenzie & Palmer, 2010)
• “This study has determined that the true cost of a 
transcutaneous measurement with BiliChek’s calibration tip and 
the labor cost involved to complete a transcutaneous 
measurement is lower in cost compared to the supplies and 















In mother baby nurses, does education on 
the use of TCBs compared to no 
education result in comparable bilirubin 
levels between serum and 
transcutaneous testing. 
P - MBU nurses 
I - Education on use of TCBs
C - No education on the use of TCBs
O - Results achieved with TCBs are 
comparable to serum bilirubin levels.
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Methods 
• Nurses on MBU began using TCBs on newborns (greater than 24 
hours old, and excluding newborns on phototherapy). 
• Documented transcutaneous and serum bilirubin results on a 
spreadsheet in the nursery. 
• Transcutaneous and serum bilirubin levels were tested at the same 
time.
• Nurses educated on use of TCBs via learning module made from 
bilirubinometer instruction manual.
• After education, MBU nurses continued to use TCBs and 
documented results.
• Bilitool.com was used to calculate the risk zone (low risk, low-
intermediate risk, high intermediate risk, and high risk) in which 
each serum and transcutaneous level fell.
• Compared accuracy (risk zones) of transcutaneous and serum 
bilirubin levels from before and after education.
• Before education on the use of TCBs: 
• 15 results were calculated to be in the same risk 
zone category.
• 14 results were calculated to be in different risk 
zone categories.
• After education on the use of TCBs:
• 23 results were calculated to be in the same risk 
zone category.
• 6 results were calculated to be in different risk zone 
categories.
• Educating MBU nurses on the use of the transcutaneous 
bilirubinometers resulted in more comparable bilirubin 
levels between serum and transcutaneous testing.
• To improve future research:
• Hold an in-service to educate nurses on how to 
correctly use bilirubinometer.
• Use a larger sample size.  
• Collect data for a longer time period.
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